Table 2.
Diagnostic tests for CHIKV infection.
| Premise | Diagnostic method | Sample types | Sensitivity (%) | Specificity (%) | Advantages | Disadvantages | References |
|---|---|---|---|---|---|---|---|
| Detection of virus | Virus isolation (in vivo or in vitro) | Serum, plasma, whole blood, and fresh or FFPE tissues | Variable | 100 | Highly specific | Technical, laborious Requires biosafety level 3 containment May take 1-2 weeks |
[1] |
|
| |||||||
| Detection of viral antigen | ELISA or immunochromatographic assay (ICA) | Serum and CSF | 85 (serum) 80 (CSF) |
89 (serum) 87 (CSF) |
Early diagnosis | Commercial assays not widely available Requires biosafety level 3 containment |
[16, 17] |
|
| |||||||
| Detection of viral nucleic acid | RT-PCR | Serum and dried blood spots | 100 | Up to 100 | Highly sensitive and specific Rapid turnaround time Multiplex available |
Expensive reagents and specialized equipment | [13, 16, 18–20] |
| Real-time RT-PCR | 100 | Up to 100 | Multiplex available | Expensive reagents and specialized equipment | |||
| Isothermal amplification methods (RT-LAMP) | 100 | 95.25 | Does not require specialized equipment (i.e., thermocyclers) | ||||
|
| |||||||
| Detection of host antibody response | ELISA | Serum CSF |
IgM: 17 (serum); 48 (CSF) IgG: 45 (serum); 63 (CSF) |
IgM: 95 (serum) IgG: 53 (serum) |
Widely available Relatively cheaper and easier to perform Rapid bedside tests are available |
Possible cross-reactivity with other alphaviruses Elevated IgM does not distinguish recent past infection from acute infection |
[4, 16, 17, 20–22] |
| IFA | Serum | 85–97 | 90–98 | Sensitive and specific Commercially available |
Lack the ability to quantify antibodies, are subjective, and require special equipment and training | ||
| PRNT | Serum | Very specific for alphaviruses; gold standard for confirmation of serologic test results | Requires the use of live virus (requires Biosafety level 3 containment) | ||||